HMGB1 and cancer: To sustain this hypothesis, it has been shown that oxaliplatin, by stimulating high-mobility group box 1 (HMGB1) protein to induce anti-cancerous T lymphocytes, can promote immune-mediated apoptosis of cancer cells [205].